What is Hello Heart?
Hello Heart is pioneering digital therapeutics specifically for heart disease. Leveraging a connected device and a mobile application, the company employs AI, behavioral science, and personalized digital coaching to foster healthier lifestyle changes among users. This approach aims to mitigate risks associated with high blood pressure and heart disease. The platform also facilitates the early detection of critically high blood pressure readings, prompting users to consult with their physicians. Designed for ease of use, Hello Heart integrates seamlessly with employer benefit ecosystems. Established in 2013, the company is recognized as a member of the American Heart Association's Innovators Network and participates in the CVS Health Point Solutions Management program.
How much funding has Hello Heart raised?
Hello Heart has raised a total of $136M across 4 funding rounds:
Series A
$9M
Series B
$12M
Series C
$45M
Series D
$70M
Series A (2018): $9M with participation from BlueRun Ventures, Resolute Ventures, and Maven Ventures
Series B (2019): $12M led by Blue Run Ventures and Khosla Ventures
Series C (2021): $45M supported by IVP, Khosla Ventures, BlueRun Ventures, Maven Ventures, and Resolute.Vc
Series D (2022): $70M featuring Stripes
Key Investors in Hello Heart
IVP
IVP (Institutional Venture Partners) is a Menlo Park-based later-stage venture capital firm that raises large growth funds and invests in high-growth technology companies, typically taking significant minority stakes and supporting companies through scaleup and IPO/M&A exits.
Khosla Ventures
Khosla Ventures provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies. The firm was founded in 2004 by Vinod Khosla, co-founder of Sun Microsystems. With over fourteen billion dollars under management, the firm focuses on a broad range of areas including consumer, enterprise, ai, fintech and financial services, semiconductors, health, agriculture/food, sustainable energy, and robotics.
Blue Run Ventures
Launched in 1998, BlueRun Ventures functions as a venture capital fund. BlueRun Ventures is headquartered in Menlo Park, California, with offices in Beijing, Helsinki, Mumbai, Seoul, and Shanghai.
What's next for Hello Heart?
The recent major strategic investment signals a pivotal phase for Hello Heart, likely enabling further expansion of its digital therapeutics platform and broader market penetration. This capital infusion is expected to fuel advancements in AI-driven coaching and the integration of its solutions within more healthcare ecosystems. As a company dedicated to combating heart disease, Hello Heart is well-positioned to capitalize on the growing demand for preventative and chronic condition management solutions, potentially leading to further strategic partnerships and scaled adoption.
See full Hello Heart company page
